Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 27, 2010

View Archived Issues

Scientists shed light on protective role of DJ-1 in Parkinson's disease and isradipine potential

ACT-178882/MK-1597 shows suitable profile for development for hypertension

Chimerix's CMX-157 is safe in first-in-human study in healthy volunteers

Novartis submits MAA to EMA for multi-component meningococcal b vaccine Bexsero

TetraLogic Pharmaceuticals claims new inhibitors of apoptosis protein inhibitors

Corcept presents phase III data for Corlux for Cushing's syndrome

Bayer Schering Pharma claims novel antagonists of proteinase-activated receptor 1

Astellas Pharma patents new inhibitors of protein kinase C theta

Cylene Pharmaceuticals divulges novel inhibitors of protein kinases

Cyclacel's cell cycle inhibitor CYC-065 suppresses growth of MM cell in vitro

HDAC inhibitor PCI-24781 displays in vivo anti-inflammatory effects

Arena and Eisai attend end-of-review meeting with FDA for lorcaserin

FDA warns about abnormal heart rhythms associated with dolasetron mesylate

Phase IIb study begins of Azixa as front-line treatment for glioblastoma multiforme

Dynavax reports data from phase Ib study of hepatitis B therapeutic vaccine DV-601

Alimera Sciences receives FDA complete response for Iluvien

New orexin receptor OX2 antagonists described by Merck & Co.

Novartis receives E.U. approval for Tasigna in newly diagnosed Ph+ CML

Teva receives FDA complete response letter for lower-volume glatiramer acetate

DSM to add to nutrition segment through acquisition of Martek

Enrollment completed in phase II study of belinostat in carcinoma of unknown primary

BioCrossroads provides support to Aarden for TB program

Oramed receives grant to support its diabetes research

Stem Cell Therapeutics meets with FDA for NTx-265 program

Meda obtains rights to market EpiPen auto-injector in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...